Prevention of RSV Bronchiolitis: An Ethical Issue
- Alberto Villani; Anna Chiara Vittucci; Livia Antilici; Mara Pisani; Rossana Scutari; Velia Di Maio
Access Resources
About
The article describes the prevention of RSV bronchiolitis in infants using nirsevimab, a newly approved treatment. It highlights Galicia's successful immunization campaign, which significantly reduced hospitalizations. The authors argue that Italy should adopt similar measures to protect young children and reduce healthcare costs. They emphasize the importance of early administration of nirsevimab for infants under six months old, as they are most vulnerable to RSV infections. The study suggests that universal prophylaxis is not only a public health necessity but also an ethical obligation to safeguard children's health during their early months of life.
Tags
More like this
The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.